Preview

Злокачественные опухоли

Расширенный поиск

Инвазивные грибковые инфекции: пересмотр определений, новое в диагностике по данным EORTC / MSGERC

https://doi.org/10.18027/2224-5057-2019-10-3s1-39-48

Полный текст:

Аннотация

Инвазивные грибковые инфекции (ИГИ) остаются важными причинами заболеваемости и смертности. Анализ международных данных в отношении ИГИ из отчетов по аутопсиям показывает, что несмотря на все наши усилия по профилактике, диагностике и лечению ИГИ все еще имеют значительную распространенность и связаны с низким уровнем прижизненной диагностики. ИГИ на аутопсии выявляют примерно в 4–5 % случаев, причем с высокой распространенностью среди пациентов с острым лейкозом и миелодиспластическим синдромом (21,7 %), что почти в шесть раз выше общей распространенности ИГИ. Консенсусные определения ИГИ согласно Европейской организации по изучению и лечению рака и Консорциума образовательных и исследовательских групп по микозам (EORTC / MSGERC) были в последний раз обновлены в 2008 году. Назрела необходимость пересмотра и обновления этого документа, и в 2019 г. были опубликованы результаты такой работы, которые и представлены в данной статье.

Об авторе

Н. С. Багирова
ФГБУ «НМИЦ онкологии им. Н. Н. Блохина» Минздрава России
Россия
Москва


Список литературы

1. Maurizio Sanguinetti, Brunella Posteraro, Catherine Beigelman – Aubry, Frederic Lamoth, Vincent Dunet, Monica Slavin8 and Malcolm D. Richardson. Diagnosis and treatment of invasive fungal infections: looking ahead. J Antimicrob Chemother 2019; 74 Suppl 2: ii27 — ii37 doi:10.1093/jac/dkz04

2. Dignani M. C. Epidemiology of invasive fungal diseases on the basis of autopsy reports. F1000Prime Reports 2014, 6. doi:10.12703/P6–81

3. Tomiteru Togano, Yuhko Suzuki, Fumihiko Nakamura, William Tse and Hikaru kume. Epidemiology of visceral mycoses in patients with acute leukemia and myelodysplastic syndrome: Analyzing the national autopsy database in Japan. Medical Mycology, 2020. doi:10.1093/mmy/myaa029. Downloaded from https://academic.oup.com/mmy/advance-articleabstract/doi/10.1093/mmy/myaa029/5836560 by National Center for Global Health and Medicine user on 13 May 2020

4. Kume H, Yamazaki T, Togano T et al. Epidemiology of visceral mycoses in autopsy cases in Japan: comparison of the data from 1989, 1993, 1997, 2001, 2005 and 2007 in Annual of Pathological Autopsy Cases in Japan. Med Mycol J. 2011; 52: 117–127

5. Солопова Г. Г., А. А. Масчан, Г. А. Новичкова. Рекомендации 2020 года по диагностике и терапии инвазивного аспергиллеза у детей с онкогематологическими заболеваниями. Вопросы гематологии / онкологии и иммунопатологии в педиатрии, 2020; 19 (1): 158–166. DOI: 10.24287/1726‑1708‑2020‑19‑1‑158‑166

6. De Pauw B, Walsh TJ, Donnelly JP, et al; European Organization for Research and Treatment of Cancer / Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer / Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC / MSG) Consensus Group. Clin Infect Dis 2008; 46:1813–21

7. Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium [published online December 5, 2019]. Clin Infect Dis. doi: 10.1093/cid/ciz1008

8. Fisher BT, Ross RK, Localio AR, Prasad PA, Zaoutis TE. Decreasing rates of invasive candidiasis in pediatric hospitals across the United States. Clin Infect Dis 2014; 58:74–7

9. Steinbach WJ, Roilides E, Berman D, et al; International Pediatric Fungal Network. Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates. Pediatr Infect Dis J 2012; 31:1252–7

10. Pana ZD, Roilides E, Warris A, Groll AH, Zaoutis T. Epidemiology of invasive fungal disease in children. J Pediatric Infect Dis Soc 2017; 6: S3–11

11. Robinson JL, Davies HD, Barton M, et al. Characteristics and outcome of infants with candiduria in neonatal intensive care — a Paediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study. BMC Infect Dis 2009; 9:183

12. Burgos A, Zaoutis TE, Dvorak CC, et al. Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics 2008; 121: e1286–94

13. Thomas KE, Owens CM, Veys PA, Novelli V, Costoli V. The radiological spectrum of invasive aspergillosis in children: a 10‑year review. Pediatr Radiol 2003; 33:453–60

14. Marchiori E, Zanetti G, Escuissato DL, et al. Reversed halo sign: highresolution CT scan findings in 79 patients. Chest 2012; 141:1260–6

15. Warris A., T. Lehrnbecher, E. Roilides, E. Castagnola, R. J. M. Brüggemann, A. H. Groll. ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children. Clinical Microbiology and Infection; 25 (2019) 1096–1113

16. Salvatore CM, Chen TK, Toussi SS, et al. (1→3) — β-d-Glucan in cerebrospinal fluid as a biomarker for Candida and Aspergillus infections of the central nervous system in pediatric patients. J Pediatric Infect Dis Soc 2016; 5:277–86

17. Thomas J . Walsh, Aspasia Katragkou, Tempe Chen, Christine M. Salvatore and Emmanuel Roilides. Invasive Candidiasis in Infants and Children: Recent Advances in Epidemiology, Diagnosis, and Treatment. J. Fungi 2019; 5, 11; doi:10.3390/jof5010011. (www.mdpi.com/journal/jof)

18. Clancy CJ, Pappas PG, Vazquez J et al. Detecting infections rapidly and easily for candidemia trial, part 2 (DIRECT2): a prospective, multicenter study of the T2Candida panel. Clin Infect Dis 2018; 66: 1678–86

19. Lim C, Seo JB, Park SY, et al. Analysis of initial and follow-up CT findings in patients with invasive pulmonary aspergillosis after solid organ transplantation. Clin Radiol 2012; 67:1179–86

20. Nam BD, Kim TJ, Lee KS, Kim TS, Han J, Chung MJ. Pulmonary mucormycosis: serial morphologic changes on computed tomography correlate with clinical and pathologic findings. Eur Radiol 2018; 28:788–95

21. Sharma P, Mukherjee A, Karunanithi S, Bal C, Kumar R. Potential role of 18FFDG PET / CT in patients with fungal infections. AJR Am J Roentgenol 2014; 203:180–9

22. World Health Organization. 2011. Rapid Advice: Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-Infected Adults, Adolescents and Children. World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int / publications / 2011 / 9789241502979_eng. pdf.

23. Jarvis JN, Percival A, Bauman S et al. Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clin Infect Dis 2011; 53: 1019–23

24. White PL, Bretagne S, Klingspor L, et al; European Aspergillus PCR Initiative. Aspergillus PCR: one step closer to standardization. J Clin Microbiol 2010; 48:1231–40

25. Schauwvlieghe AFAD, Vonk AG, Buddingh EP, et al. Detection of azolesusceptible and azole-resistant Aspergillus coinfection by cyp51A PCR amplicon melting curve analysis. J Antimicrob Chemother 2017; 72:3047–50

26. Chong GL, van de Sande WW, Dingemans GJ, et al. Validation of a new Aspergillus real-time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid. J Clin Microbiol. 2015; 53:868–74

27. White PL, Posso RB, Barnes RA. Analytical and clinical evaluation of the PathoNostics AsperGenius assay for detection of invasive aspergillosis and resistance to azole antifungal drugs directly from plasma samples. J Clin Microbiol 2017; 55:2356–66

28. Jarvis JN, Lawn SD, Vogt M, Bangani N, Wood R, Harrison TS. Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa. Clin Infect Dis 2009; 48:856–62

29. McKinnell JA, Cannella AP, Kunz DF, et al. Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV) — infected and HIV-uninfected persons. Transpl Infect Dis 2012; 14:510–8

30. Pagano L, Fianchi L, Mele L, et al. Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years’ experience of infection in GIMEMA centres. Br J Haematol; 117:379–86.

31. Roux A, Gonzalez F, Roux M, et al; Groupe de recherche respiratoire en reanimation en onco-hematologie (Grrr-OH). Update on pulmonary Pneumocystis jirovecii infection in non-HIV patients. Med Mal Infect 2014; 44:185–98


Для цитирования:


Багирова Н.С. Инвазивные грибковые инфекции: пересмотр определений, новое в диагностике по данным EORTC / MSGERC. Злокачественные опухоли. 2020;10(3s1):39-48. https://doi.org/10.18027/2224-5057-2019-10-3s1-39-48

For citation:


. Инвазивные грибковые инфекции: пересмотр определений, новое в диагностике по данным EORTC / MSGERC. Malignant tumours. 2020;10(3s1):39-48. (In Russ.) https://doi.org/10.18027/2224-5057-2019-10-3s1-39-48

Просмотров: 57


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2224-5057 (Print)
ISSN 2587-6813 (Online)